Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 22Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Monocytic, Acute 5Myelodysplastic Syndromes 4Leukemia, Promyelocytic, Acute 4Leukemia, Myelomonocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Multiple Myeloma 3Lymphoma 3Neoplasms, Plasma Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Carcinoma, Hepatocellular 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1Philadelphia Chromosome 1Neutropenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Immunotherapy, Adoptive 2flumatinib 1fludarabine 1Thiotepa 1Sensitivity and Specificity 1Imatinib Mesylate 1Idarubicin 1Diagnosis 1Deferasirox 1Decitabine 1Daunorubicin 1Cytarabine 1Cladribine 1Busulfan 1Blood Specimen Collection 1Azacitidine 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid × Idarubicin × Clear all
NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

University Hospital Muenster

Phase 2/3 Unknown
550 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡